BTIG Downgrades DexCom (DXCM) to Neutral
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
BTIG downgraded DexCom (NASDAQ: DXCM) from Buy to Neutral and removed its price target. Analyst Sean Lavin thinks shares are fairly valued given the stock's run.
"While we do not think shares are overvalued and could argue for a bit more upside as revenue should continue to exceed guidance in our opinion, we do feel a lot of good news is priced in, and given the historical volatility we would like more significant upside than we see at this time to maintain our Buy rating. One additional issue is investors are starting to focus on margins and profitability," said Lavin.
Shares of DexCom closed at $91.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Stifel Downgrades Boston Properties Inc. (BXP) to Hold
- Jefferies Cuts Price Target on Essendant (ESND) to $18 Following EPS Miss
- Rosenblatt Upgrades NETGEAR (NTGR) to Buy
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!